Literature DB >> 19707889

Vasospasm and statin therapy: yet another cautionary tale.

Alejandro A Rabinstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19707889     DOI： 10.1007/s12028-009-9267-z

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  21 in total

1.  Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage.

Authors:  Matthew J McGirt; John R Lynch; Augusto Parra; Huaxin Sheng; Robert D Pearlstein; Daniel T Laskowitz; Dale A Pelligrino; David S Warner
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.

Authors:  Augusto Parra; Kurt T Kreiter; Susan Williams; Robert Sciacca; William J Mack; Andrew M Naidech; Christopher S Commichau; Brian-Fred M Fitzsimmons; Nazli Janjua; Stephan A Mayer; E Sander Connolly
Journal:  Neurosurgery       Date:  2005-03       Impact factor: 4.654

3.  Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience.

Authors:  Matthew J McGirt; Robert Blessing; Michael J Alexander; Shahid M Nimjee; Graeme F Woodworth; Allan H Friedman; Carmelo Graffagnino; Daniel T Laskowitz; John R Lynch
Journal:  J Neurosurg       Date:  2006-11       Impact factor: 5.115

4.  Statins may not protect against vasospasm in subarachnoid haemorrhage.

Authors:  Michael Kern; Mark M F Lam; Neville W Knuckey; Christopher R P Lind
Journal:  J Clin Neurosci       Date:  2009-02-23       Impact factor: 1.961

Review 5.  Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Jason L Trimble; Denise R Kockler
Journal:  Ann Pharmacother       Date:  2007-11-06       Impact factor: 3.154

6.  Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial.

Authors:  Ming-Yuan Tseng; Peter J Hutchinson; Carole L Turner; Marek Czosnyka; Hugh Richards; John D Pickard; Peter J Kirkpatrick
Journal:  J Neurosurg       Date:  2007-12       Impact factor: 5.115

7.  A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage.

Authors:  Sherry H-Y Chou; Eric E Smith; Neeraj Badjatia; Raul G Nogueira; John R Sims; Christopher S Ogilvy; Guy A Rordorf; Cenk Ayata
Journal:  Stroke       Date:  2008-07-24       Impact factor: 7.914

8.  Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis.

Authors:  Victoria A H Sillberg; George A Wells; Jeffrey J Perry
Journal:  Stroke       Date:  2008-07-24       Impact factor: 7.914

Review 9.  Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study.

Authors:  Matthew J McGirt; Giannina L Garces Ambrossi; Judy Huang; Rafael J Tamargo
Journal:  J Neurosurg       Date:  2009-05       Impact factor: 5.115

10.  Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial.

Authors:  Ming-Yuan Tseng; Marek Czosnyka; Hugh Richards; John D Pickard; Peter J Kirkpatrick
Journal:  Stroke       Date:  2005-08       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.